| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |